Effect of Preoperative N-Acetylcysteine on Postoperative Blood Loss Parameters in Cardiac Surgery Patients

Table 1

Patient demographics.

Variable	N-acetylcysteine group (𝑛=79)	Control group (𝑛=106)	P Value
Age in years^a	67.3 ± 9.1	65.5 ± 10.8	.233
Gender			.456
Males	72.2%	79.2%
Females	27.8%	20.8%
Baseline ADP inhibitor use	5.6%	4.7%	.451
Baseline aspirin use	92.4%	96.2%	.508
History of diabetes	58.2%	35.8%	.007
History of dyslipidemia	83.3%	82.1%	.451
History of hypertension	86.1%	75.5%	.029
Type of surgery			.001
CABG only	70.9%	85.8%
Valve only	6.3%	5.7%
CABG + Valve	7.6%	4.7%
Other^b	15.2%	3.8%
Height (cm)^a	172 ± 9.9	172 ± 9.0	.952
Weight (kg)^a	88.9 ± 22.9	88.5 ± 19.1	.908

^aMean ± standard deviation.
^bTransmyocardial revascularization (TMR) or MAZE procedure.
CABG: coronary artery bypass graft.
ADP: adenosine diphosphate.